or Try an Advanced Search...

    Technical Analysis for ACIU - AC Immune SA

    Grade Last Price % Change Price Change
    F 2.35 2.62% 0.06
    ACIU closed up 2.62 percent on Friday, April 26, 2024, on 56 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ACIU trend table...
    Date Alert Name Type % Chg
    Earnings Movers Other 0.00%
    Outside Day Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 2.62%
    Down 3 Days in a Row Weakness 2.62%
    Oversold Stochastic Weakness 2.62%
    Wide Bands Range Expansion -0.84%
    Oversold Stochastic Weakness -0.84%
    Oversold Stochastic Weakness -1.26%
    Oversold Stochastic Weakness -2.89%
    Older End-of-Day Signals for ACIU ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 10 DMA about 14 hours ago
    Rose Above Previous Day's High about 16 hours ago
    10 DMA Resistance about 16 hours ago
    Outside Day about 16 hours ago
    Up 5% about 16 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ACIU Chart by TradingView
    Basic chart:

    Profile

    AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimer’s and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinson's, and focuses on producing therapeutic and diagnostic product candidates, using SupraAntigen and Morphomer technology platforms. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta and Morphomer alpha-syn, among others.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biology Organ Systems Imaging Alzheimer's Disease Parkinson's Disease Neurological Disorders Dementia Neurodegenerative Diseases Psychiatric Diagnosis Glaucoma Degenerative Disease Neurodegeneration Imaging Agent Amyloid Beta Company's Pipeline

    Is ACIU a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 15 Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%
    Jan 22 Roche ends AC Immune partnership for Alzheimer’s drugs
    Jan 22 AC Immune to Regain Global Rights to Crenezumab and Semorinemab
    Jan 18 AC Immune (ACIU) is a Great Momentum Stock: Should You Buy?
    Jan 8 5 Small-Cap Stocks to Play the January Effect
    Jan 3 AC Immune (ACIU) Upgraded to Buy: Here's Why
    Jan 3 AC Immune issues updates on Phase 2 studies, cash runway
    Jan 3 AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
    Dec 18 AC Immune: Initial AD Findings Bring About Two Upcoming Catalysts
    Dec 15 AC Immune Alzheimer's drug advanced into Phase 2b testing
    See more ACIU news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.14
    52 Week Low 1.78
    Average Volume 193,671
    200-Day Moving Average 3.22
    50-Day Moving Average 3.09
    20-Day Moving Average 2.58
    10-Day Moving Average 2.39
    Average True Range 0.21
    RSI (14) 31.97
    ADX 32.51
    +DI 13.71
    -DI 22.72
    Chandelier Exit (Long, 3 ATRs) 2.55
    Chandelier Exit (Short, 3 ATRs) 2.88
    Upper Bollinger Bands 2.96
    Lower Bollinger Band 2.20
    Percent B (%b) 0.2
    BandWidth 29.40
    MACD Line -0.22
    MACD Signal Line -0.22
    MACD Histogram -0.001
    Fundamentals Value
    Market Cap 232.18 Million
    Num Shares 98.8 Million
    EPS -0.94
    Price-to-Earnings (P/E) Ratio -2.50
    Price-to-Sales 284765.75
    Price-to-Book 1.86
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.72
    Resistance 3 (R3) 2.73 2.61 2.66
    Resistance 2 (R2) 2.61 2.52 2.61 2.64
    Resistance 1 (R1) 2.48 2.46 2.55 2.47 2.62
    Pivot Point 2.37 2.37 2.40 2.36 2.37
    Support 1 (S1) 2.23 2.27 2.30 2.23 2.08
    Support 2 (S2) 2.12 2.21 2.12 2.06
    Support 3 (S3) 1.99 2.12 2.04
    Support 4 (S4) 1.98